美国
证券交易委员会
华盛顿特区20549
表格
(标记一)
根据1934年证券交易法第13或15(d)条,本季度报告 |
截至季度结束日期的财务报告
或者
根据1934年证券交易法第13或15(d)条的转型报告 |
过渡期从 到
委员会文件号
(根据其章程规定的注册人准确名称)
| ||
(国家或其他管辖区的 | (IRS雇主 |
(总部地址)(邮政编码)
(
(注册人电话号码,包括区号)
无数据
(前名称、地址及财政年度,如果自上次报告以来有更改)
在法案第12(b)条的规定下注册的证券:
每一类的名称 |
| 交易标志 |
| 在其上注册的交易所的名称 |
本基金寻求于东欧地区注册的主要权益关联发行人的长期升值投资。 |
请在以下勾选,并注明是否为以下两项:(1)在过去12个月内(或注册者需要提交此类报告的较短期间内)提交所有必须提交的根据1934年证券交易法第13或第15(d)条规定提交的报告,并且(2)在过去90天内受到此类提交要求的要求。(小型报告公司)
请在以下勾选方框表示注册人是否已在Regulation S-T Rule 405规定的前12个月(或在注册人需要提交此类文件的较短期间内)提交了每个互动数据文件。
请勾选标记以说明注册人是大型快速申报人、加速申报人、非加速申报人、较小的报告公司还是新兴成长型公司。请查看《交易所法》第120亿.2条中“大型快速申报人”、“加速申报人”、“较小的报告公司”和“新兴成长型公司”的定义。
| 如果是新兴增长公司,请勾选是否注册人选择不使用执行交易所第13(a)条规定所提供的任何新的或修订的财务会计准则的推迟过渡期。 ☐☐ | |
非加速归档企业☐ | 小型报表公司 | |
新兴成长公司 |
如果是新兴成长型企业,请勾选复选标记,表明注册者已选择不使用延长过渡期来符合根据证券交易法第13(a)条规定提供的任何新财务会计准则。 ☐
请勾选表示注册申报人是否为外壳公司(根据交易所12b-2号规则定义)。是
截至2024年10月21日,有
第一部分—财务信息
项目1.基本报表
OSI SYSTEMS,INC.及附属公司
简化联合资产负债表(未经审计)
(金额以千为单位,股份数量和面值除外)
6月30日, | 2021年9月30日 | |||||
| 2024 |
| 2024 | |||
资产 | ||||||
流动资产: | ||||||
现金及现金等价物 | $ | | $ | | ||
2,687,823 |
| |
| | ||
存货 |
| |
| | ||
预付费用和其他流动资产 |
| |
| | ||
总流动资产 |
| |
| | ||
资产和设备,净值 |
| |
| | ||
商誉 |
| |
| | ||
无形资产, 净额 |
| |
| | ||
其他 |
| |
| | ||
总资产 | $ | | $ | | ||
负债和股东权益 | ||||||
流动负债: | ||||||
银行信贷额度 | $ | | $ | | ||
开多次数 |
| |
| | ||
应付账款 |
| |
| | ||
应计的工资和相关费用 |
| |
| | ||
来自客户预付款 |
| |
| | ||
其他应计费用和流动负债 |
| |
| | ||
流动负债合计 |
| |
| | ||
长期负债净额 |
| |
| | ||
其他长期负债 |
| |
| | ||
负债合计 |
| |
| | ||
股东权益: | ||||||
6.40 | ||||||
优先股,$0.0001 |
|
| ||||
普通股,每股面值为 $0.0001; |
| |
| | ||
保留盈余 |
| |
| | ||
累计其他综合损失 |
| ( |
| ( | ||
股东权益总额 |
| |
| | ||
负债和股东权益总额 | $ | | $ | |
请参阅附注事项的简明合并财务报表。
3
OSI 系统公司和子公司
简明合并运营报表(未经审计)
(金额以千计,每股数据除外)
截至9月30日的三个月 | ||||||
| 2023 |
| 2024 | |||
净收入: | ||||||
产品 | $ | | $ | | ||
服务 |
| |
| | ||
净收入总额 |
| |
| | ||
销售商品的成本: | ||||||
产品 |
| |
| | ||
服务 |
| |
| | ||
销售商品的总成本 |
| |
| | ||
毛利润 |
| |
| | ||
运营费用: | ||||||
销售、一般和管理 |
| |
| | ||
研究和开发 |
| |
| | ||
重组和其他费用,净额 |
| |
| | ||
运营费用总额 |
| |
| | ||
运营收入 |
| |
| | ||
利息和其他费用,净额 |
| ( |
| ( | ||
所得税前收入 |
| |
| | ||
所得税准备金 |
| ( |
| ( | ||
净收入 | $ | | $ | | ||
每股收益: | ||||||
基本 | $ | | $ | | ||
稀释 | $ | | $ | | ||
每股计算中使用的股份: | ||||||
基本 |
| |
| | ||
稀释 |
| |
| |
参见简明合并财务报表的附注。
4
5
OSI SYSTEMS,INC.及附属公司
未经审计的凝聚的股东权益合并报表
(金额以千为单位,除每股数据外)
2023年9月30日结束的三个月 | ||||||||||||||
累积的 | ||||||||||||||
普通股 | 其他 | |||||||||||||
| 股数 |
|
| 留存收益 |
| 综合 |
| |||||||
| 股份 |
| 数量 |
| 收益 |
| 损失 |
| 总费用 | |||||
资产负债表—2023年6月30日 |
| | $ | | $ | | $ | ( | $ | | ||||
行使股票期权 |
| | | — | — | | ||||||||
限制性股票单位的解除限制 |
| | — | — | — | — | ||||||||
员工股票购买计划下发行的股票 |
| | | — | — | | ||||||||
股票补偿费用 |
| — | | — | — | | ||||||||
与股份奖励净结算相关的支付的税额 |
| ( | ( | ( | — | ( | ||||||||
净收入 |
| — | — | | — | | ||||||||
其他综合损失 |
| — | — | — | ( | ( | ||||||||
资产负债表-2023年9月30日 | | $ | | $ | | $ | ( | $ | |
2024年9月30日结束的三个月 | ||||||||||||||
累积的 | ||||||||||||||
普通股 | 其他 | |||||||||||||
| 股数 |
|
| 留存收益 |
| 综合 |
| |||||||
| 股份 |
| 数量 |
| 收益 |
| 损失 |
| 总费用 | |||||
结余-2024年6月30日 | | $ | | $ | | $ | ( | $ | | |||||
行使股票期权 | | | — | — | | |||||||||
限制性股票单位的解除限制 | | — | — | — | — | |||||||||
员工股票购买计划下发行的股票 | | | — | — | | |||||||||
股票补偿费用 | — | | — | — | | |||||||||
回购普通股 | ( | ( | ( | — | ( | |||||||||
与股份奖励净结算相关的支付的税额 | ( | ( | ( | — | ( | |||||||||
净收入 | — | — | | — | | |||||||||
其他综合损失 | — | — | — | ( | ( | |||||||||
资产负债表-2024年9月30日 |
| | $ | | $ | | $ | ( | $ | |
6
OSI SYSTEMS,INC.及附属公司
未经审计的简明合并现金流量表
(金额以千为单位)
截至9月30日,三个月的结束 | ||||||
| 2023 |
| 2024 | |||
经营活动产生的现金流量 |
| |||||
净收入 | $ | | $ | | ||
| ||||||
折旧和摊销 |
| |
| | ||
股票补偿费用 |
| |
| | ||
应收账款损失的回收 | ( | ( | ||||
延迟所得税 | |
| ( | |||
摊销债务折扣和发行成本 |
| — | | |||
其他 |
| | ( | |||
业务收购前后经营资产和负债的变动: | ||||||
应收账款 |
| |
| ( | ||
存货 |
| ( |
| ( | ||
预付款项和其他资产 |
| ( |
| ( | ||
应付账款 |
| |
| ( | ||
应计的工资和相关费用 | ( | ( | ||||
来自客户预付款 |
| |
| | ||
递延收入 | ( | | ||||
其他 |
| ( |
| | ||
经营活动产生的净现金流量 |
| |
| ( | ||
投资活动产生的现金流量 | ||||||
购置房地产和设备 |
| ( |
| ( | ||
出售固定资产的收益 | | | ||||
存入资金购买存单 | ( | — | ||||
来自存单到期的收益 | | — | ||||
业务收购,扣除现金收购 |
| — |
| ( | ||
支付无形资产和其他资产 |
| ( |
| ( | ||
投资活动产生的净现金流出 |
| ( |
| ( | ||
筹资活动产生的现金流量 | ||||||
银行信贷额度上的净借款(还款) |
| |
| ( | ||
获得长期债务 |
| |
| | ||
开多期债偿付款 |
| ( |
| ( | ||
行权期权和员工股票购买计划所得款项 |
| |
| | ||
支付或准备支付的参考负债 | ( | ( | ||||
回购普通股 |
| — |
| ( | ||
与股份奖励净结算相关的支付的税额 |
| ( |
| ( | ||
筹集资金的净现金流量 |
| ( |
| | ||
汇率变动对现金的影响 |
| |
| | ||
现金及现金等价物的净增加(减少) |
| |
| ( | ||
现金及现金等价物—期初余额 |
| |
| | ||
现金及现金等价物—期末余额 | $ | | $ | | ||
现金流量补充披露: | ||||||
期间支付的净现金 | ||||||
利息 | $ | | $ | | ||
所得税 | $ | | $ | |
请参阅附注事项的简明合并财务报表。
7
OSI SYSTEMS,INC.及附属公司
简明合并财务报表附注
(未经审计)
1.报表的基础
简明综合财务报表包括OSI Systems,Inc.及其子公司的账户。所有重要的公司间账户和交易在合并中已被消除。简明综合财务报表是由管理层按照美国通用会计原则(“GAAP”)和与美国证券交易委员会(“SEC”)的规则和法规一起编制的。根据SEC的规则和法规以及适用于未经审计的中期财务报表的GAAP要求,某些年度财务报表所需的信息和脚注披露已被简化或排除。因此,简明综合财务报表不包括GAAP要求的所有年度财务报表所需的信息和脚注。据管理层意见,简明综合财务报表反映了出于公平呈现中期所示结果而被认为是必要的常规性质的所有调整。这些建议的简明综合财务报表和所附说明应与我们2024财年截至6月30日的已向SEC提交的10-k表格年度报告中包括的审计合并财务报表和所附说明一起阅读。2024年9月30日结束的三个月的运营结果不一定能体现预期的2025财年整个期间或任何未来期间的运营结果。
使用估计
根据GAAP要求编制符合会计准则的基本财务报表,需要管理层对资产和负债的报告金额、与规定的资产和负债有关的披露,以及销售金额、销售成本和报表期间费用的金额进行估计和假设。由于涉及到估计和假设,对于我们公司来说,最重要的估计和假设涉及合同收入、企业并购中取得的资产的公允价值和承担的负债、按成本或净可变现价值较低报告的存货价值、以市场为基础的股票补偿费用、所得税、应计质保费用、有关的考虑、坏账准备、以及长期资产、可识别无形资产和商誉的计量、有用寿命和估计金额的回收性等。估计的变化将在知晓的期间内反映。由于估计涉及的固有不确定性,我们未来报告的实际金额与估计金额可能有实质差异。
每股收益计算
我们通过将归属于普通股股东的净利润除以期间内普通股平均股数来计算基本每股收益。我们通过将归属于普通股股东的净利润除以期间内普通股平均股数和潜在稀释性普通股数的和来计算稀释每股收益。潜在普通股包括根据库藏股法行使股票期权和限制性股票单元奖励而发行的股份。基础权益组成部分
下表列出基本每股收益和摊薄每股收益的计算(以千为单位,除每股金额外):
| 截至9月30日,三个月的结束 | |||||
2023 |
| 2024 | ||||
净利润可供普通股股东分配 | $ | | $ | | ||
|
| |
| | ||
股权奖励的稀释效应 |
| |
| | ||
稀释后加权平均发行股份 |
| |
| | ||
基本每股收益 | $ | | $ | | ||
摊薄每股收益 | $ | | $ | | ||
由于其抗稀释效应而被排除在稀释每股收益之外的股份 | | |
8
现金及现金等价物
我们将所有到期日在收购日期之日起三个月或更短期限的高度流动的投资视为现金等价物。
截至2023年和2024年6月30日,我们的现金及现金等价物总额分别为$
金融工具的公允价值
我们的财务工具主要包括现金及现金等价物、保险公司合同、应收账款、应付账款、债务工具、利率互换合同和外币远期合同。除长期债务工具和我们的利率互换合同外,财务工具的账面价值由于其短期到期性质而代表其公允价值。我们的长期债务工具的账面价值被认为近似其公允价值,因为这些工具的利率是变量的或与我们可以获得的当前融资利率相当。截至2024年6月30日和2024年9月30日,我们的外币远期合同的公允价值并不重要。
公允价值是在计量日期市场参与者之间进行有序交易时,在资产销售或过户负债时将收到的价格或支付的价格。"一级"类别包括在活跃市场上报价的相同资产和负债。"二级"类别包括除报价市场价格之外的可观察输入的资产和负债。"三级"类别包括用于公允价值衡量的估值技术是未观察到且对公允价值测量具有重大影响的资产和负债。我们与收购相关的计提支付义务,详见简明合并财务报表附注10,为公允价值衡量目的属于"三级"类别。
我们的财务资产和负债的公允价值分别按以下方式分类(以千为单位):
| 2024年6月30日 |
| 2024年9月30日 | |||||||||||||||||||||
| 第一层次 |
| 第二层次 |
| 第三层次 |
| 总费用 |
| 第一层次 |
| 第二层次 |
| 第三层次 |
| 总费用 | |||||||||
我公司截至2023年和2024年6月30日的外汇远期合约的未实现收益和损失均不显著。 | $ | — | $ | | $ | — | $ | | $ | — | $ | | $ | — | $ | | ||||||||
资产 – 利率互换合同 | $ | — | $ | | $ | — | $ | | $ | — | $ | | $ | — | $ | | ||||||||
Liabilities—Convertible debt | $ | — | $ | — | $ | — | $ | — | $ | — | $ | | $ | — | $ | | ||||||||
负债-附带条件支出 | $ | — | $ | — | $ | | $ | | $ | — | $ | — | $ | | $ | |
衍生工具和对冲活动
我们对衍生工具的使用包括外币远期合约和利率互换协议。我们利用外币远期合约部分减轻某些资产负债表暴露,或将其用作净投资套期保值工具,以防范短期外币波动带来的潜在变化。这些合约的原始到期期限最长为三个月。我们还通过衍生工具管理利率变化风险。我们使用固定利率互换来有效地将部分变动利率付款转换为固定利率付款。我们不会出于投机目的使用套期保值工具。
来自我们的外币远期合约的净收益或损失,并未被指定为套期工具,将在合并利润表中报告,截至2023年9月30日和2024年的三个月内,报告的金额并不显著。我们外币远期合约的公允价值是使用标准估值模型和合同期内基于市场的可观察性输入进行估算的。未实现收益被确认为资产,未实现损失被确认为负债。截至2024年6月30日和2024年9月30日,我们持有的外币远期合约名义金额共计$
9
我们进行利率互换协议是为了改善与基于担保隔夜融资利率(“SOFR”)债务相关的利息支付的现金流可预测性。该利率互换于2026年12月到期。利率互换被视为有效的现金流量套期保值,并且因此,该工具上的净收益或损失作为其他综合收益(损失)的组成部分,在我们的合并财务报表中报告,并在被套期限的基础利率影响盈利时重新分类为净利润。利率互换套期保值的定性和定量评估每季度进行一次,除非事实和情况表明对冲可能不再高度有效。
截至2024年6月30日和2024年9月30日,被指定为利率互换套期保值的衍生工具名义金额为$ million。
现金流量套期保值对其他综合收益(损失)和收益的影响如下所示:
| 截至9月30日,三个月的结束 | |||||
2023 |
| 2024 | ||||
在压缩的合并利润表中呈现的总利息和其他费用净额中记录了现金流避险的影响 | $ | ( | $ | ( | ||
其他综合收益(损失)(税后净额) | |
| ( | |||
从累积其他综合收益(损失)重新分类的金额,净利息费用 | |
| |
最近的会计声明
偶尔,由财务会计准则委员会(“FASB”)和其他监管机构发布新的会计准则,这些准则将在指定的生效日期采纳。除非另有讨论,管理层认为,尚未生效的最近发布的准则对我们的合并财务报表在采纳后不会产生重大影响。在2025财年第一季度,没有采纳新的准则。
2023年11月,FASB发布了《2013-07号会计准则更新》,即《关于报告性部门披露的改进》(ASU 2023-07),该更新要求按部门披露重大费用,并要求揭示此前要求的年度披露项的中期披露。ASU 2023-07要求按照追溯制度应用,并于2023年12月15日后开始的财年和2024年12月15日后开始的财年内的中期披露中生效,允许提前采纳。我们正在评估ASU 2023-07对我们合并财务报表中披露的潜在影响。
2023年12月,FASB发布了《2013-09号会计准则更新》,即《关于所得税披露的改进》(ASU 2023-09),主要涉及额外披露主要与所得税率调和和所得税支付有关。ASU 2023-09要求实体每年披露所得税率调和,使用金额和百分比,考虑到包括州和地方所得税、外国税收影响、税收抵免或不可抵税项目等多个调和项目类别。披露的调和项目受数量门槛限制,并按性质和司法管辖区分开。ASU 2023-09还要求向联邦、州和外国司法管辖区披露净所得税支付或获得的信息,以及按照各司法管辖区披露,受到5%的数量门槛限制。ASU 2023-09可以按照前瞻性或追溯性采纳,并于2024年12月15日后开始的财年生效,允许提前采纳。我们正在评估ASU 2023-09对我们合并财务报表中披露的潜在影响。
10
2。业务组合
在会计准则编纂主题805下, 业务合并 (“ASC 805”),收购会计方法要求我们按收购之日的估计公允价值记录收购的资产减去收购所承担的负债。总估计收购价格超过所收购净资产的估计公允价值的任何部分都应记作商誉。此类估值要求管理层做出重要的估计和假设,尤其是对无形资产的估值和假设。对某些无形资产进行估值的重要估计包括但不限于来自并购客户的未来预期现金流、收购的技术、商品名称、使用寿命和贴现率。管理层对公允价值的估计基于假设,这些假设被认为是合理的,但本质上是不确定和不可预测的,因此,实际业绩可能与估计有所不同。在自收购之日起最长一年的公允价值计量期内,随着收购之日存在的其他信息的出现,我们可能会记录对收购的初步资产和承担的负债的调整。计量期结束后,任何后续调整均包含在收益中。
2025 财年业务收购
2024 年 9 月,我们(通过我们的安全部门)收购了
2024 财年业务收购
2023 年 12 月,我们(通过我们的光电子和制造部门)以约美元的价格收购了一家私人合同制造商
2023 年 10 月,我们(通过我们的安全部门)以约美元的价格收购了一家私营的辐射探测技术提供商
11
3. Balance Sheet Details
The following tables set forth details of selected balance sheet accounts (in thousands):
June 30, | September 30, | |||||
Accounts receivable, net |
| 2024 |
| 2024 | ||
Accounts receivable | $ | | $ | | ||
Less allowance for doubtful accounts |
| ( |
| ( | ||
Total | $ | | $ | |
June 30, | September 30, | |||||
Inventories |
| 2024 |
| 2024 | ||
Raw materials | $ | | $ | | ||
Work-in-process |
| |
| | ||
Finished goods |
| |
| | ||
Total | $ | | $ | |
June 30, | September 30, | |||||
Property and equipment, net |
| 2024 |
| 2024 | ||
Land | $ | | $ | | ||
Buildings, civil works and improvements |
| |
| | ||
Leasehold improvements |
| |
| | ||
Equipment and tooling |
| |
| | ||
Furniture and fixtures |
| |
| | ||
Computer equipment |
| |
| | ||
Computer software |
| |
| | ||
Computer software implementation in process | | | ||||
Construction in process |
| |
| | ||
Total |
| |
| | ||
Less accumulated depreciation and amortization |
| ( |
| ( | ||
Property and equipment, net | $ | | $ | |
Depreciation and amortization expense for property and equipment was $
4. Goodwill and Intangible Assets
The changes in the carrying value of goodwill by segment for the three-month period ended September 30, 2024 were as follows (in thousands):
Optoelectronics | ||||||||||||
and | ||||||||||||
Security | Manufacturing | Healthcare | ||||||||||
| Division |
| Division |
| Division |
| Consolidated | |||||
Balance as of June 30, 2024 | $ | | $ | | $ | | $ | | ||||
Goodwill acquired during the period (see Note 2) |
| | — | — | | |||||||
Foreign currency translation adjustment |
| | | | | |||||||
Balance as of September 30, 2024 | $ | | $ | | $ | | $ | |
12
Intangible assets consisted of the following (in thousands):
June 30, 2024 | September 30, 2024 | |||||||||||||||||
Gross | Gross | |||||||||||||||||
Carrying | Accumulated | Intangibles | Carrying | Accumulated | Intangibles | |||||||||||||
| Value |
| Amortization |
| Net |
| Value |
| Amortization |
| Net | |||||||
Amortizable assets: | ||||||||||||||||||
Software development costs | $ | | $ | ( | $ | | $ | | $ | ( | $ | | ||||||
Patents |
| | ( | | | ( | | |||||||||||
Developed technology |
| | ( | | | ( | | |||||||||||
Customer relationships |
| | ( | | | ( | | |||||||||||
Total amortizable assets |
| | ( | | | ( | | |||||||||||
Non-amortizable assets: | ||||||||||||||||||
Trademarks |
| | — | | | — | | |||||||||||
Total intangible assets | $ | | $ | ( | $ | | $ | | $ | ( | $ | |
During the three months ended September 30, 2024 intangible assets of $
Amortization expense related to intangible assets was $
At September 30, 2024, the estimated future amortization expense for amortizable intangible assets was as follows (in thousands):
Fiscal Year
2025 (remaining 9 months) |
| $ | |
2026 |
| | |
2027 |
| | |
2028 |
| | |
2029 | | ||
Thereafter |
| | |
Total | $ | |
Software development costs for software products incurred before establishing technological feasibility are charged to operations. Software development costs incurred after establishing technological feasibility are capitalized on a product-by-product basis until the product is available for general release to customers at which time amortization begins. Annual amortization, charged to cost of goods sold, is the amount computed using the ratio that current revenues for a product bear to the total current and anticipated future revenues for that product. In the event that future revenues are not estimable, such costs are amortized on a straight-line basis over the remaining estimated economic life of the product. Amortizable assets that have not yet begun to be amortized are included in Thereafter in the table above. For the three months ended September 30, 2023 and 2024, we capitalized software development costs in the amounts of $
5. Contract Assets and Liabilities
We enter into contracts to sell products and provide services, and we recognize contract assets and liabilities that arise from these transactions. We recognize revenue and corresponding accounts receivable according to ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). When we recognize revenue in advance of the point in time at which contracts give us the right to invoice a customer, we record this as unbilled revenue, which is included in accounts receivable, net, on the consolidated balance sheets. We may also receive consideration, per the terms of a contract, from customers prior to transferring control of goods to the customer. We record customer deposits as contract liabilities. Additionally, we may receive payments, most typically under service and warranty contracts, at the onset of the contract and before services have been performed. In such instances, we record a deferred revenue liability in either Other accrued expenses and current liabilities or Other long-term liabilities. We recognize these contract liabilities as sales after all revenue recognition criteria are met.
13
The table below shows the balance of contract assets and liabilities as of June 30, 2024 and September 30, 2024, including the change between the periods. There were no substantial non-current contract assets for the periods presented.
Contract Assets (in thousands)
| June 30, |
| September 30, |
|
|
| ||||||
| 2024 |
| 2024 |
| Change |
| % Change |
| ||||
Unbilled revenue (included in accounts receivable, net) | $ | | $ | | $ | |
| | % |
Contract Liabilities (in thousands)
| June 30, |
| September 30, |
|
|
| ||||||
| 2024 |
| 2024 |
| Change |
| % Change | |||||
Advances from customers | $ | | $ | | $ | | | % | ||||
Deferred revenue—current |
| |
| |
| | | % | ||||
Deferred revenue—long-term |
| |
| |
| | | % |
Contract Assets. Contract assets increased by approximately $
Remaining Performance Obligations. Remaining performance obligations related to ASC 606 represent the portion of the transaction price allocated to performance obligations under an original contract with a term greater than one year which are fully or partially unsatisfied at the end of the period. As of September 30, 2024, the portion of the transaction price allocated to remaining performance obligations was approximately $
Practical Expedients. In cases where we are responsible for shipping after the customer has obtained control of the goods, we have elected to treat the shipping activities as fulfillment activities rather than as separate performance obligations. Additionally, we have elected to capitalize the cost to obtain a contract only if the period of
6. Leases
The components of operating lease expense were as follows (in thousands):
Three Months Ended September 30, | ||||||
| 2023 |
| 2024 | |||
Operating lease cost | $ | | $ | | ||
Variable lease cost | |
| | |||
Short-term lease cost | |
| | |||
$ | | $ | |
14
Supplemental disclosures related to operating leases were as follows (in thousands):
| Balance Sheet Category |
| June 30, 2024 |
| September 30, 2024 | ||||
Operating lease right of use (“ROU”) assets, net |
| $ | | $ | | ||||
Operating lease liabilities, current portion |
| $ | | $ | | ||||
Operating lease liabilities, long-term |
|
| |
| | ||||
Total operating lease liabilities | $ | | $ | | |||||
Weighted average remaining lease term |
|
| |||||||
Weighted average discount rate |
|
| | % |
Supplemental cash flow information related to operating leases was as follows (in thousands):
| Three Months Ended September 30, | |||||
| 2023 |
| 2024 | |||
Cash paid for operating lease liabilities | $ | | $ | | ||
ROU assets obtained in exchange for new lease obligations |
| |
| |
Maturities of operating lease liabilities at September 30, 2024 were as follows (in thousands):
| September 30, 2024 | ||
Less than one year | $ | | |
1 – 2 years |
| | |
2 – 3 years |
| | |
3 – 4 years |
| | |
4 – 5 years |
| | |
Thereafter |
| | |
| | ||
Less: imputed interest |
| ( | |
Total lease liabilities | $ | |
7. Restructuring and Other Charges
We endeavor to align our global capacity and infrastructure with demand by our customers and to effectively integrate acquisitions and thereby improve our operational efficiency.
During the three months ended September 30, 2024, we recognized $
During the three months ended September 30, 2023, we recognized $
15
The following tables summarize restructuring and other charges for the periods set forth below (in thousands):
Three Months Ended September 30, 2023 | |||||||||||||||
|
| Optoelectronics and |
|
|
| ||||||||||
Manufacturing | Healthcare | ||||||||||||||
| Security Division |
| Division |
| Division |
| Corporate |
| Total | ||||||
Acquisition-related costs | $ | | $ | — | $ | — | $ | — | $ | | |||||
Employee termination costs | | — | — | | | ||||||||||
Facility closures/consolidation |
| — |
| |
| — |
| — |
| | |||||
Legal costs, net |
| | — | — | | | |||||||||
Total | $ | | $ | | $ | — | $ | | $ | |
Three Months Ended September 30, 2024 | |||||||||||||||
Optoelectronics and | |||||||||||||||
Manufacturing | Healthcare | ||||||||||||||
| Security Division |
| Division |
| Division |
| Corporate |
| Total | ||||||
Acquisition-related costs | $ | | $ | — | $ | — | $ | — | $ | | |||||
Employee termination costs | | | | — | | ||||||||||
Facility closures/consolidation | | | — | — | | ||||||||||
Total | $ | | $ | | $ | | $ | — | $ | |
The accrued liability for restructuring and other charges is included in Other accrued expenses and current liabilities in the condensed consolidated balance sheets. The changes in the accrued liability for restructuring and other charges for the three-month period ended September 30, 2024 were as follows (in thousands):
Facility | |||||||||||||||
Acquisition- | Employee | Closure/ | Legal | ||||||||||||
Related | Termination | Consolidation | Costs and | ||||||||||||
| Costs |
| Costs |
| Cost |
| Settlements |
| Total | ||||||
Balance as of June 30, 2024 | $ | | $ | | $ | | $ | | $ | | |||||
Restructuring and other charges, net |
| | | |
| — | | ||||||||
Payments, adjustments and reimbursements, net |
| ( | ( | ( |
| ( | ( | ||||||||
Balance as of September 30, 2024 | $ | | $ | | $ | | $ | | $ | |
8. Borrowings
Revolving Credit Facility
Our senior secured credit facility comprises a term loan and a $
16
2.25% Convertible Senior Notes Due 2029
In July 2024, we issued an aggregate of $
The 2029 Notes are unsecured obligations which bear regular interest at
Holders of the 2029 Notes may convert all or a portion of their 2029 Notes at their option prior to May 1, 2029, in multiples of $
On or after May 1, 2029, the 2029 Notes are convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Holders of the 2029 Notes who convert the 2029 Notes in connection with a make-whole fundamental change, as defined in the indenture governing the 2029 Notes, or in connection with a redemption may be entitled to an increase in the conversion rate.
We accounted for the issuance of the 2029 Notes as a single liability measured at its amortized cost, as no other embedded features require bifurcation and recognition as derivatives. The following table is a summary of the 2029 Notes as of September 30, 2024 (in thousands):
| September 30, | ||
2024 | |||
Principal amount | $ | | |
Unamortized debt discount and issuance costs |
| ( | |
Net carrying amount | $ | | |
Fair value (Level 2) | $ | |
The 2029 Notes were not eligible for conversion as of September 30, 2024. No sinking fund is provided for the 2029 Notes, which means that we are not required to redeem or retire them periodically. As of September 30, 2024 we were in compliance with applicable covenants under the indenture governing the 2029 Notes.
For the three months ended September 30, 2024, total interest expense for the 2029 Notes was $
17
Other Borrowings
Several of our foreign subsidiaries maintain bank lines of credit, denominated in local currencies and U.S. dollars, primarily for the issuance of letters of credit. As of September 30, 2024, $
Long-term debt consisted of the following (in thousands):
| June 30, | September 30, | ||||
| 2024 |
| 2024 | |||
Term loan | $ | | $ | | ||
2029 Notes, net | — | | ||||
Other long-term debt |
| |
| | ||
| |
| | |||
Less current portion of long-term debt |
| ( |
| ( | ||
Long-term portion of debt | $ | | $ | |
Future principal payments of long-term debt by fiscal year as of September 30, 2024 are as follows (in thousands):
2025 (9 months remaining) |
| $ | |
2026 |
| | |
2027 |
| | |
2028 |
| | |
2029 and thereafter |
| | |
Total | $ | |
9. Stockholders’ Equity
Stock-based Compensation
As of September 30, 2024, we maintained the Amended and Restated 2012 Incentive Award Plan (the “OSI Plan”) as a stock-based employee compensation plan.
We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):
Three Months Ended September 30, | ||||||
| 2023 |
| 2024 | |||
Cost of goods sold | $ | | $ | | ||
Selling, general and administrative | | | ||||
Research and development | | | ||||
Stock-based compensation expense | $ | | $ | |
As of September 30, 2024, total unrecognized compensation cost related to share-based compensation grants under the OSI Plan were estimated at $
18
The following summarizes stock option activity during the three months ended September 30, 2024:
Weighted | ||||||||||
Average | Weighted-Average | Aggregate | ||||||||
Number of | Exercise | Remaining Contractual | Intrinsic Value | |||||||
| Options |
| Price |
| Term |
| (in thousands) | |||
Outstanding at June 30, 2024 |
| |
| $ | |
| ||||
Granted |
| — | — | |||||||
Exercised |
| ( | | |||||||
Expired or forfeited |
| — | — | |||||||
Outstanding at September 30, 2024 |
| | $ | | $ | | ||||
Exercisable at September 30, 2024 | | $ | |
| $ | |
The following summarizes RSU award activity during the three months ended September 30, 2024:
Weighted- | |||||
Average | |||||
| Shares |
| Fair Value | ||
Nonvested at June 30, 2024 |
| | $ | | |
Granted |
| | | ||
Vested |
| ( | | ||
Forfeited |
| ( | | ||
Nonvested at September 30, 2024 |
| | $ | |
As of September 30, 2024, there were approximately
We granted
Stock Repurchase Program
In September 2022, our Board of Directors increased the stock repurchase authorization to a total of
During the three months ended September 30, 2024, we repurchased
Dividends
We have not paid any dividends since the consummation of our initial public offering in 1997 and we do not currently intend to pay any dividends in the foreseeable future. Our Board of Directors will determine the payment of future dividends, if any. Certain of our current bank credit facilities restrict the payment of dividends and future borrowings may contain similar restrictions.
19
10. Commitments and Contingencies
Acquisition-Related Contingent Obligations
Under the terms and conditions of the purchase agreements associated with certain acquisitions, we may be obligated to make additional payments based on the achievement of certain sales or profitability milestones through the acquired operations. For agreements that contain contingent consideration obligations that are capped, the remaining maximum amount of such potential future payments is $
Projections and estimated probabilities are used to estimate future contingent earnout payments, which are discounted back to present value to compute contingent earnout liabilities. The following table provides a roll-forward from June 30, 2024 to September 30, 2024 of the contingent consideration liability, which is included in Other accrued expenses and current liabilities and other long-term liabilities in our consolidated balance sheets (in thousands):
Beginning fair value, June 30, 2024 |
| $ | |
Business acquisition (Note 2) | | ||
Foreign currency translation adjustment | | ||
Changes in fair value for contingent earnout obligations |
| ( | |
Payments on contingent earnout obligations |
| ( | |
Ending fair value, September 30, 2024 | $ | |
Environmental Contingencies
We are subject to various environmental laws. We conduct environmental investigations at our manufacturing facilities in North America, Asia-Pacific, and Europe, and, to the extent practicable, on all new properties in order to identify, as of the date of such investigation, potential areas of environmental concern related to past and present activities or from nearby operations. In certain cases, we have conducted further environmental assessments consisting of soil and groundwater testing and other investigations deemed appropriate by independent environmental consultants.
We have not accrued for loss contingencies relating to environmental matters because we believe that, although unfavorable outcomes are possible, they are not considered by our management to be probable and reasonably estimable. If one or more of these environmental matters are resolved in a manner adverse to us, the impact on our business, financial condition, results of operations and cash flow could be material.
Indemnifications and Certain Employment-Related Contingencies
In the normal course of business, we have agreed to indemnify certain parties with respect to certain matters. We have agreed to hold certain parties harmless against losses arising from a breach of representations, warranties or covenants, or intellectual property infringement or other claims made by third parties. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. In addition, we have entered into indemnification agreements with our directors and certain of our officers. It is not possible to determine the maximum potential amount under these indemnification agreements due to, among other factors, the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. We have not recorded any liability for costs related to contingent indemnification obligations as of September 30, 2024.
Product Warranties
We offer our customers warranties on many of the products that we sell. These warranties typically provide for repairs and maintenance of the products if problems arise during a specified time period after original shipment. Concurrent with the sale of products, we record a provision for estimated warranty expenses with a corresponding increase in cost of goods sold. We periodically adjust this provision based on historical experience and anticipated expenses. We charge actual expenses of repairs under warranty, including parts and labor, to this provision when incurred. The current obligation for warranty provision is included in other accrued expenses and current liabilities and the noncurrent portion is included in other long-term liabilities in the consolidated balance sheets.
20
The following table presents changes in warranty provisions (in thousands):
Three Months Ended September 30, | ||||||
| 2023 |
| 2024 | |||
Balance at beginning of period | $ | | $ | | ||
Additions | | | ||||
Reductions for warranty repair costs and adjustments |
| ( |
| ( | ||
Balance at end of period | $ | | $ | |
Legal Proceedings
In February 2023, one of our subsidiaries received a subpoena from the U.S. Department of Justice (“DoJ”). The subpoena was issued as part of a DoJ case against a former employee of an OSI Systems subsidiary for embezzlement and other conduct occurring before he was hired by our subsidiary and while he was employed by another company in the United States and Mexico. The subpoena requests documents and records relating to, among other things, the former employee and the Company’s business dealings in Mexico since 2020. In February 2024, we received a follow-up subpoena requesting the same categories of documents but extending the relevant time period through to the date of the second subpoena. We have produced documents in response to these subpoenas and intend to cooperate with any further subpoenas or other requests in connection with this or any ensuing investigation. In September 2024, we received a subpoena requesting records relating to certain entities in Honduras. Consistent with past practice, we intend to cooperate with requests arising from this most recent subpoena.
We are involved in various other potential or actual claims and legal proceedings arising in the ordinary course of business. In our opinion after consultation with legal counsel, the ultimate disposition of such proceedings is not likely to have a material adverse effect on our business, financial condition, results of operations or cash flows. We have not accrued for loss contingencies relating to any non-ordinary course matters because we believe that, although unfavorable outcomes in the proceedings are possible, they are not considered by management to be probable and reasonably estimable. If one or more of these matters are resolved in a manner adverse to our Company, the impact on our business, financial condition, results of operations and cash flows could be material.
11. Income Taxes
The determination of the annual effective tax rate is based upon a number of significant estimates and judgments, including the estimated annual pretax income in each tax jurisdiction in which we operate and the development of tax planning strategies during the year. In addition, as a global commercial enterprise, our tax expense can be impacted by changes in tax rates or laws, the finalization of tax audits and reviews and other factors that cannot be predicted with certainty. As such, there can be significant volatility in interim tax provisions.
The effective tax rates for the three months ended September 30, 2023 and 2024 were
21
12. Segment Information
We have determined that we operate in
The following tables present our results of operations and identifiable assets by industry segment (in thousands):
Three Months Ended | ||||||
September 30, | ||||||
| 2023 |
| 2024 | |||
Revenues (1) —by Segment: | ||||||
Security division | $ | | $ | | ||
Optoelectronics and Manufacturing division, including intersegment revenues | | | ||||
Healthcare division | | | ||||
Intersegment revenues elimination | ( | ( | ||||
Total | $ | | $ | | ||
Income (loss) from operations —by Segment: | ||||||
Security division | $ | | $ | | ||
Optoelectronics and Manufacturing division | | | ||||
Healthcare division | | | ||||
Corporate | ( | ( | ||||
Intersegment Eliminations | | ( | ||||
Total | $ | | $ | |
June 30, | September 30, | |||||
| 2024 |
| 2024 | |||
Assets (2) —by Segment: | ||||||
Security division | $ | | $ | | ||
Optoelectronics and Manufacturing division |
| |
| | ||
Healthcare division | |
| | |||
Corporate |
| |
| | ||
Eliminations (3) |
| ( |
| ( | ||
Total | $ | | $ | |
22
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
In this report, “OSI”, the “Company”, “we”, “us”, “our” and similar terms refer to OSI Systems, Inc. together with our wholly-owned subsidiaries.
This management’s discussion and analysis of financial condition as of September 30, 2024 and results of operations for the three months ended September 30, 2024 should be read in conjunction with management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 filed with the SEC.
Forward-Looking Statements
This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements relate to our current expectations, beliefs, and projections concerning matters that are not historical facts. Words such as “project,” “believe,” “anticipate,” “plan,” “expect,” “intend,” “may,” “should,” “will,” “would,” and similar words and expressions are intended to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions and contingencies, many of which are outside our control. Assumptions upon which our forward-looking statements are based could prove to be inaccurate, and actual results may differ materially from those expressed in or implied by such forward-looking statements. Important factors that could cause our actual results to differ materially from our expectations are disclosed in this report, our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (including Part I, Item 1, “Business,” Part I, Item 1A, “Risk Factors” and Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”) and other documents filed by us from time to time with the SEC. Such factors, of course, do not include all factors that might affect our business and financial condition. We could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; the impact of potential information technology, cybersecurity or data security breaches; changes in domestic and foreign government spending, budgetary, procurement and trade policies adverse to our businesses; the impact of the Russia-Ukraine conflict or conflicts in the Middle East, including the potential for broad economic disruption; global economic uncertainty; material delays and cancellations of orders or deliveries thereon, supply chain disruptions, plant closures, or other adverse impacts on our ability to execute business plans; unfavorable currency exchange rate fluctuations; effect of changes in tax legislation; market acceptance of our new and existing technologies, products and services; our ability to win new business and convert any orders received to sales within the fiscal year; contract and regulatory compliance matters, and actions, which if brought, could result in judgments, settlements, fines, injunctions, debarment or penalties; as well as other risks and uncertainties, including but not limited to those factors described in our other SEC filings. All forward-looking statements contained in this report are qualified in their entirety by this Section. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Investors should not place undue reliance on forward-looking statements as a prediction of actual results. We undertake no obligation other than as may be required under securities laws to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Executive Summary
We are a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications. We sell our products and provide related services in diversified markets, including homeland security, healthcare, defense and aerospace. We have three operating divisions: (a) Security, providing security and inspection systems and turnkey security screening solutions; (b) Optoelectronics and Manufacturing, providing specialized electronic components for our Security and Healthcare divisions, as well as to third parties for applications in the defense and aerospace markets, among others; and (c) Healthcare, providing patient monitoring, cardiology and remote monitoring, and connected care systems and associated accessories.
Security Division. Security and inspection products are used in airports and at a wide range of other facilities such as border crossings, seaports, freight forwarding operations (to screen cargo before it is loaded onto airplanes and ships), government and military installations, sports and concert venues, correctional facilities, and other locations where the interdiction of criminal activities is paramount. The U.S. Department of Homeland Security has undertaken numerous initiatives to prevent terrorists from entering the
23
country, hijacking airplanes, and obtaining and transporting explosives, weapons and their components, and to prevent human trafficking, among other serious crimes. These initiatives, such as the Customs-Trade Partnership Against Terrorism, the U.S. Transportation Security Administration’s Air Cargo Screening Mandate and the U.S. Customs and Border Protection Container Security Initiative, have resulted in increased demand for security and inspection products, as have similar programs undertaken by governments around the world. Revenues from our Security division accounted for 59% and 65% of our total consolidated revenues for the three months ended September 30, 2023 and 2024, respectively.
Optoelectronics and Manufacturing Division. Through our Optoelectronics and Manufacturing division, we design, manufacture and market optoelectronic devices and flex circuits and provide electronics manufacturing services globally for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostics, telecommunications, office automation, computer peripherals, industrial automation and consumer products. We also provide our optoelectronic devices and electronics manufacturing services to OEM customers and to our own Security and Healthcare divisions. Revenues from external customers in our Optoelectronics and Manufacturing division accounted for 28% and 24% of our total consolidated revenues for the three months ended September 30, 2023 and 2024, respectively.
Healthcare Division. Through our Healthcare division, we design, manufacture, market and service patient monitoring, cardiology and remote monitoring, and connected care systems globally for sale primarily to hospitals and medical centers. Our products monitor patients in critical, emergency and perioperative care areas of the hospital and provide information, through wired and wireless networks, to physicians and nurses who may be at the patient’s bedside, in another area of the hospital or even outside the hospital. Revenues from our Healthcare division accounted for 13% and 11% of our total consolidated revenues for the three months ended September 30, 2023 and 2024, respectively.
Trends and Uncertainties
The following is a discussion of certain trends and uncertainties that we believe have influenced, and may continue to influence, our results of operations.
Global Economic Considerations. Our products and services are sold in numerous countries worldwide, with a large percentage of our sales generated outside the United States. We are exposed to and impacted by global macroeconomic factors, U.S. and foreign government policies and foreign exchange fluctuations. There is uncertainty surrounding macroeconomic factors in the U.S. and globally characterized by supply chain disruptions, inflationary pressure, and labor shortages. Increasing diplomatic and trade friction between the U.S. and China has also created significant uncertainty in the global economy. These global macroeconomic factors, coupled with political unrest internationally and the volatile U.S. political climate, including uncertainty regarding the upcoming U.S. presidential election, have created uncertainty and impacted demand for certain of our products and services. Conflicts in Gaza and nearby regions have created political and economic uncertainty in the Middle East. Also, the continued conflict between Russia and Ukraine and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. We do not know how long this uncertainty will continue. These factors could have a material adverse effect on our business, results of operations and financial condition.
Global Trade. The current domestic and international political environment, including in relation to recent and further potential changes by the U.S. and other countries in policies on global trade and tariffs, have resulted in uncertainty surrounding the future state of the global economy and global trade. This uncertainty is exacerbated by sanctions imposed by the U.S. government against certain businesses and individuals in select countries. Continued or increased uncertainty regarding global trade due to these or other factors may require us to modify our current business practices and could have a material adverse effect on our business, results of operations and financial condition.
Healthcare Considerations. Our Healthcare division experienced some increased demand for its patient monitoring products as a result of the COVID-19 pandemic during the earlier stages of the pandemic. Certain hospitals are facing significant financial pressure as supply chain constraints and inflation drive up operating costs, and higher interest rates make access to credit more expensive. Continuation of these macroeconomic conditions would likely have an adverse impact on hospitals’ spend on capital equipment and thereby could have a material adverse effect on our business, results of operations and financial condition.
Government Policies. Our results of operations and cash flows could be materially affected by changes in U.S. or foreign government legislative, regulatory or enforcement policies.
24
Russia’s Invasion of Ukraine. The invasion of Ukraine by Russia and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. This has the potential to indirectly disrupt our supply chain and access to certain resources. While we have not experienced significant adverse impacts to date and will continue to monitor for any impacts and seek to mitigate disruption that may arise, we have certain research and development activities within Ukraine for our Healthcare division which have been somewhat impacted. The conflict also has increased the threat of malicious cyber activity from nation states and other actors.
Currency Exchange Rates. On a year-over-year basis, currency exchange rates negatively impacted reported sales by approximately 0.7% for the three months ended September 30, 2024 compared to the three months ended September 30, 2023, primarily due to the strengthening of the U.S. dollar against other foreign currencies in 2024. Any further strengthening of the U.S. dollar against foreign currencies would adversely impact our sales for the remainder of the fiscal year, and any weakening of the U.S. dollar against foreign currencies would positively impact our sales for the remainder of the fiscal year.
Results of Operations for the Three Months Ended September 30, 2023 (Q1 Fiscal 2024) Compared to the Three Months Ended September 30, 2024 (Q1 Fiscal 2025) (amounts in millions)
Net Revenues
The table below and the discussion that follows are based upon the way in which we analyze our business. See Note 12 to the condensed consolidated financial statements for additional information about our business segments.
| Q1 |
| % of |
| Q1 |
| % of |
|
|
| ||||||
| Fiscal 2024 |
| Net Revenues |
| Fiscal 2025 |
| Net Revenues |
| $ Change |
| % Change |
| ||||
Security |
| $ | 164.6 | 59.0 | % | $ | 224.3 | 65.2 | % | $ | 59.7 | 36.3 | % | |||
Optoelectronics and Manufacturing | 76.8 |
| 27.5 | 82.6 | 24.0 | 5.8 | 7.6 | |||||||||
Healthcare | 37.8 |
| 13.5 | 37.1 | 10.8 | (0.7) | (1.9) | |||||||||
Total net revenues |
| $ | 279.2 | 100 | % | $ | 344.0 | 100.0 | % | $ | 64.8 | 23.2 | % |
Revenues for the Security division during Q1 fiscal 2025 increased year-over-year due to increases in product and service revenues of approximately $52.1 million and $7.6 million, respectively. The increase in product revenues was primarily driven by growth in cargo and vehicle inspection systems, trace detections systems, checkpoint screening sales, and the acquired business further described in Note 2 to the condensed consolidated financial statements. The increase in service revenue was due primarily to an increase in the installed base of products.
Revenues for the Optoelectronics and Manufacturing division during Q1 fiscal 2025 increased year-over-year as a result of an increase in revenues in our contract manufacturing business of approximately $7.4 million, offset by a decrease in revenues in our optoelectronics business of approximately $1.6 million.
Revenues for the Healthcare division during Q1 fiscal 2025 decreased year-over-year due to lower product sales of $2.2 million, partially offset by an increase in service revenues of $1.5 million.
25
Gross Profit
Q1 | % of | Q1 | % of | ||||||||
| Fiscal 2024 |
| Net Revenues |
| Fiscal 2025 |
| Net Revenues |
| |||
Gross profit | $ | 98.7 | 35.4 | % | $ | 121.5 | 35.3 | % |
Gross profit is impacted by sales volume and changes in overall manufacturing-related costs, such as raw materials and component costs, warranty expense, provision for inventory, freight, and logistics. Gross profit increased approximately $22.8 million in Q1 fiscal 2025 as compared to the prior year driven by the increase in sales. Our cost of goods sold increased year-over-year primarily as a result of the increase in revenues.
Operating Expenses
Q1 |
| % of |
| Q1 | % of | |||||||||||
| Fiscal 2024 |
| Net Revenues |
| Fiscal 2025 |
| Net Revenues |
| $ Change |
| % Change | |||||
Selling, general and administrative |
| $ | 59.8 |
| 21.4 | % | $ | 72.2 | 21.0 | % | $ | 12.4 | 20.7 | % | ||
Research and development |
| 15.9 |
| 5.7 | 17.8 | 5.2 |
| 1.9 | 11.9 | |||||||
Impairment, restructuring and other charges, net |
| 0.5 |
| 0.2 | 1.2 | 0.3 |
| 0.7 | 140.0 | |||||||
Total operating expenses | $ | 76.2 |
| 27.3 | % | $ | 91.2 | 26.5 | % | $ | 15.0 | 19.7 | % |
Selling, general and administrative. Our significant selling, general and administrative (“SG&A”) expenses include employee compensation, sales commissions, travel, professional services, marketing expenses, foreign currency translation, and depreciation and amortization expense. SG&A expense for Q1 fiscal 2025 was $12.4 million higher than in the same prior-year period primarily due to unfavorable foreign currency exchange rates and an increase in employee compensation in Q1 fiscal 2025 to support the growth of the Company as compared to the same prior-year period.
Research and development. Research and development (“R&D”) expenses include research related to new product development and product enhancements. R&D expenses increased $1.9 million in Q1 fiscal 2025 as compared to Q1 fiscal 2024 driven by increased compensation costs to support new product development initiatives primarily in our Security division.
Restructuring and other charges. Restructuring and other charges generally consist of costs relating to reductions in our workforce, facilities consolidation, costs related to acquisition activity, and other non-recurring charges. During Q1 fiscal 2025, restructuring and other charges consisted of $0.4 million for acquisition activity and $0.8 million related to employee terminations, and legal and other costs. During Q1 fiscal 2024, restructuring and other charges consisted of $0.2 million for acquisition activity and $0.3 million related to employee terminations, and legal and other costs.
Interest and Other Expense, Net
Q1 | % of | Q1 | % of |
| |||||||
| Fiscal 2024 |
| Net Revenues |
| Fiscal 2025 |
| Net Revenues |
| |||
Interest and other expense, net | $ | 5.7 |
| 2.0 | % | $ | 7.4 |
| 2.2 | % |
Interest and other expense, net. For Q1 fiscal 2025, interest and other expense, net was $7.4 million as compared to $5.7 million in the same prior-year period. This increase was driven by higher average levels of borrowings primarily to support the increase in working capital associated with the growth in revenues and for the repurchase of approximately $80 million of common stock in July 2024.
Income taxes. The effective tax rate for a particular period varies depending on a number of factors, including (i) the mix of income earned in various tax jurisdictions, each of which applies a unique range of income tax rates and income tax credits, (ii) changes in previously established valuation allowances for deferred tax assets (changes are based upon our current analysis of the likelihood that these deferred tax assets will be realized), (iii) the level of non-deductible expenses, (iv) certain tax elections (v) tax holidays granted to certain of our international subsidiaries and (vi) discrete tax items. For Q1 fiscal 2025 and 2024, we recognized a provision for income taxes of $5.0 million and $3.9 million, respectively. The effective tax rates for Q1 fiscal 2025 and 2024 were 21.9% and 23.4%, respectively. During Q1 fiscal 2025 and 2024, we recognized a net discrete tax benefit of $0.5 million and $0.4 million, respectively, related to equity-based compensation under ASU 2016-09.
26
Liquidity and Capital Resources
Our principal sources of liquidity are our cash and cash equivalents, cash generated from operations and our credit facilities. Cash and cash equivalents totaled $85.1 million at September 30, 2024, a decrease of $10.3 million, or 11%, from $95.4 million at June 30, 2024. We currently anticipate that our available funds, credit facilities and cash flow from operations will be sufficient to meet our operational cash needs for the next 12 months and the foreseeable future beyond that. In addition, we anticipate that cash generated from operations, without repatriating earnings from our non-U.S. subsidiaries, and our credit facilities will be sufficient to satisfy our obligations in the U.S.
In July 2024, we issued an aggregate of $350.0 million principal amount of 2.25% convertible senior notes due in August 2029 In connection with the issuance of the 2029 Notes, we repurchased 531,314 shares of our common stock for approximately $80 million.
Our credit facility comprises a term loan and a $600 million revolving credit facility, which includes a $300 million sub-facility for letters of credit. As of September 30, 2024, there was $133.8 million outstanding under the term loan, $259.0 million outstanding under our revolving credit facility and $77.1 million of outstanding letters of credit. As of September 30, 2024, the total amount available under our revolving credit facility was $263.9 million. See Note 8 to the consolidated financial statements for further discussion.
Cash Provided by (Used in) Operating Activities. Cash flows from operating activities can fluctuate significantly from period to period, as net income, adjusted for non-cash items, and working capital fluctuations impact cash flows. During Q1 fiscal 2025, we used cash from operations of $37.2 million compared to cash provided by operations of $17.1 million in the comparable prior-year period. The net change in cash flows from operating activities was due primarily to a net increase in accounts receivable, inventories and other current assets in the Security division, partially offset by other changes in net working capital.
Cash Used in Investing Activities. Net cash used in investing activities was $87.5 million for Q1 fiscal 2025 as compared to $9.6 million in the same prior-year period. We used $75.5 million for a business acquisition during the three-month period ended September 30, 2024. Capital expenditures in the three-month period ended September 30, 2024 were $7.7 million compared to $5.2 million in the same prior-year period. Expenditures for intangible and other assets in the three-month period ended September 30, 2024 were $4.4 million compared to $4.2 million in the same prior-year period.
Cash Used in Financing Activities. Net cash provided by financing activities was $113.8 million during Q1 fiscal 2025, compared to $1.9 million used during the same prior-year period. The change in cash flows from financing activities was primarily due to net proceeds of $340.4 million from the 2029 Notes, partially offset by (1) net repayment of $125.0 million on our credit facility and (2) repurchase of common shares of $80.4 million. Taxes paid related to net share settlement of equity awards was $21.3 million during Q1 fiscal 2025 compared to $22.2 million in the same prior-year period.
Borrowings
See Note 8 to the condensed consolidated financial statements for a detailed discussion regarding our revolving credit facility and other borrowings.
Cash Held by Foreign Subsidiaries
Our cash and cash equivalents totaled $85.1 million at September 30, 2024. Of this amount, approximately 81% was held by our foreign subsidiaries and subject to repatriation tax considerations. These foreign funds were held primarily by our subsidiaries in the, India, UK, Singapore, Canada and Malaysia and to a lesser extent in Mexico, Egypt, Indonesia, Albania, and Australia among other countries. We intend to permanently reinvest certain earnings from foreign operations, and we currently do not anticipate that we will need this cash in foreign countries to fund our U.S. operations. In the event we repatriate cash from certain foreign operations and if taxes have not previously been withheld on the related earnings, we would provide for withholding taxes at the time we change our intention with regard to the reinvestment of those earnings.
27
Issuer Purchases of Equity Securities
The following table contains information about the shares of common stock we purchased during the quarter ended September 30, 2024:
|
|
|
|
|
| Maximum number (or | |||
approximate dollar | |||||||||
value) of | |||||||||
Total number of | shares (or | ||||||||
shares (or units) | units) | ||||||||
purchased as | that may | ||||||||
Total number of | Average price | part of publicly | yet be purchased | ||||||
shares (or units) | paid per share (or | announced plans or | under the plans or | ||||||
| purchased |
| unit) |
| programs |
| programs (1) | ||
July 1 to July 31, 2024 |
| 531,314 | $ | 150.57 |
| 531,314 |
| 1,190,556 | |
August 1 to August 31, 2024 |
| — | $ | — |
| — |
| 1,190,556 | |
September 1 to September 30, 2024 |
| — | $ | — |
| — |
| 1,190,556 | |
| 531,314 |
| 531,314 |
(1) | In September 2022, when there were 1,131,301 shares remaining authorized to repurchase under the then-existing share repurchase program, the Board of Directors renewed the authorization and revised the maximum number of shares to 2,000,000 shares authorized under the stock repurchase program. Upon repurchase, shares of common stock are restored to the status of authorized but unissued shares, and we record them as a reduction in the number of shares of common stock issued and outstanding in our consolidated financial statements. |
Contractual Obligations
During the first quarter of fiscal year 2025, there were no material changes outside the ordinary course of business to the information regarding specified contractual obligations contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. See Notes 1, 6, 8 and 10 to the condensed consolidated financial statements for additional information regarding our contractual obligations.
Recent Accounting Pronouncements
From time to time, new accounting pronouncements are issued by the FASB and other regulatory bodies that are adopted as of the specified effective dates. Unless otherwise discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on our Consolidated Financial Statements upon adoption. As discussed in Note 1, we are currently evaluating the potential impact on financial statement disclosures upon future adoption of ASU 2023 - 07 and ASU 2023 - 09. There were no new pronouncements adopted in the first quarter of fiscal year 2025.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
For a discussion of our exposure to market risk, refer to our market risk disclosures set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. There have been no material changes in our exposure to market risk during the three months ended September 30, 2024 from that described in the Annual Report.
28
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
As of September 30, 2024, the end of the period covered by this report, our management, including our Chief Executive Officer and our Chief Financial Officer, reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act). Based upon management’s review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the SEC and is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the first quarter of fiscal 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud within the Company have been detected.
29
PART II—OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
From time to time, we are subject to litigation and other legal proceedings and claims arising in the ordinary course of our business or otherwise. More information regarding legal proceedings in which we are involved can be found under Note 10, “Commitments and Contingencies” of the Notes to the Consolidated Financial Statements in Part I, Item 1 of this Report, which is incorporated by reference into this Item 1.
ITEM 1A. RISK FACTORS
The discussion of our business, financial condition and results of operations in this Quarterly Report on Form 10-Q for the period ended September 30, 2024 should be read together with the risk factors contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, filed with the SEC on August 29, 2024, which describe various risks and uncertainties that could materially affect our business, financial condition and results of operations in the future. There have been no material changes to the risk factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
See Issuer Purchases of Equity Securities discussion under Part I, Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations, which is incorporated by reference into this Item 2.
In July 2024, we issued an aggregate of $350.0 million principal amount of 2.25% convertible senior notes due in August 2029. The 2029 Notes were issued to the initial purchasers in reliance upon Section 4(a)(2) of the Securities Act in transactions not involving any public offering. The 2029 Notes were resold by the initial purchasers to persons whom the initial purchasers reasonably believe are “qualified institutional buyers,” as defined in, and in accordance with, Rule 144A under the Securities Act. Any shares of our common stock that may be issued upon conversion of the 2029 Notes will be issued in reliance upon Section 3(a)(9) of the Securities Act as involving an exchange by us exclusively with our security holders. Initially, a maximum of 2,324,490 shares of our common stock may be issued upon conversion of the 2029 Notes based on the initial maximum conversion rate of 6.6414 shares of common stock per $1,000 principal amount of 2029 Notes which is subject to customary anti-dilution adjustment provisions.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable
ITEM 5. OTHER INFORMATION
Our directors and officers (as defined in Rule 16a-1 under the Exchange Act) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1 (c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the first quarter of fiscal 2025, none of our directors or officers informed us of the
, or of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as those terms are defined in Regulation S-K, Item 408.30
ITEM 6. EXHIBITS
Exhibit |
| Description |
4.1 | ||
4.2 | ||
31.1 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1 | Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2 | Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
101.INS | XBRL Instance Document | |
101.SCH | Inline XBRL Taxonomy Extension Schema | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase | |
104 | Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101) |
(1)Previously filed with our Current Report on Form 8-K filed on July 19, 2024.
31
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, in the City of Hawthorne, State of California on the 25th day of October 2024.
OSI SYSTEMS, INC. | ||
By: | /s/ Deepak Chopra | |
Deepak Chopra | ||
President and Chief Executive Officer | ||
(Principal Executive Officer) | ||
By: | /s/ Alan Edrick | |
Alan Edrick | ||
Executive Vice President and Chief Financial Officer | ||
(Principal Financial Officer) | ||
By: | /s/ Cary Okawa | |
Cary Okawa | ||
Chief Accounting Officer | ||
(Principal Accounting Officer) |
32